Balagué C - Search Results

1

Replicative adenoviruses for cancer therapy.

Alemany R, Balagué C, Curiel DT. Alemany R, et al. Among authors: balague c. Nat Biotechnol. 2000 Jul;18(7):723-7. doi: 10.1038/77283. Nat Biotechnol. 2000. PMID: 10888838 Review.

2

Gene therapy for gliomas: molecular targets, adenoviral vectors, and oncolytic adenoviruses.

Alemany R, Gomez-Manzano C, Balagué C, Yung WK, Curiel DT, Kyritsis AP, Fueyo J. Alemany R, et al. Among authors: balague c. Exp Cell Res. 1999 Oct 10;252(1):1-12. doi: 10.1006/excr.1999.4623. Exp Cell Res. 1999. PMID: 10502394 Review.

3

Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoter.

Nettelbeck DM, Rivera AA, Balagué C, Alemany R, Curiel DT. Nettelbeck DM, et al. Among authors: balague c. Cancer Res. 2002 Aug 15;62(16):4663-70. Cancer Res. 2002. PMID: 12183423

4

Activation of adenovirus early promoters and lytic phase in differentiated strata of organotypic cultures of human keratinocytes.

Noya F, Balagué C, Banerjee NS, Curiel DT, Broker TR, Chow LT. Noya F, et al. Among authors: balague c. J Virol. 2003 Jun;77(11):6533-40. doi: 10.1128/jvi.77.11.6533-6540.2003. J Virol. 2003. PMID: 12743310 Free PMC article.

5

Human papillomavirus E6E7-mediated adenovirus cell killing: selectivity of mutant adenovirus replication in organotypic cultures of human keratinocytes.

Balagué C, Noya F, Alemany R, Chow LT, Curiel DT. Balagué C, et al. J Virol. 2001 Aug;75(16):7602-11. doi: 10.1128/JVI.75.16.7602-7611.2001. J Virol. 2001. PMID: 11462032 Free PMC article.

6

A novel E1A-E1B mutant adenovirus induces glioma regression in vivo.

Gomez-Manzano C, Balague C, Alemany R, Lemoine MG, Mitlianga P, Jiang H, Khan A, Alonso M, Lang FF, Conrad CA, Liu TJ, Bekele BN, Yung WK, Fueyo J. Gomez-Manzano C, et al. Among authors: balague c. Oncogene. 2004 Mar 11;23(10):1821-8. doi: 10.1038/sj.onc.1207321. Oncogene. 2004. PMID: 15014451

7

Development and application of a minimal-adenoviral vector system for gene therapy of hemophilia A.

Zhang WW, Josephs SF, Zhou J, Fang X, Alemany R, Balagué C, Dai Y, Ayares D, Prokopenko E, Lou YC, Sethi E, Hubert-Leslie D, Kennedy M, Ruiz L, Rockow-Magnone S. Zhang WW, et al. Among authors: balague c. Thromb Haemost. 1999 Aug;82(2):562-71. Thromb Haemost. 1999. PMID: 10605752 Review.

8

A cutaneous gene therapy approach to treat infection through keratinocyte-targeted overexpression of antimicrobial peptides.

Carretero M, Del Río M, García M, Escámez MJ, Mirones I, Rivas L, Balague C, Jorcano JL, Larcher F. Carretero M, et al. Among authors: balague c. FASEB J. 2004 Dec;18(15):1931-3. doi: 10.1096/fj.04-1515fje. Epub 2004 Sep 29. FASEB J. 2004. PMID: 15456737

9

Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome.

Balagúe C, Kalla M, Zhang WW. Balagúe C, et al. J Virol. 1997 Apr;71(4):3299-306. doi: 10.1128/JVI.71.4.3299-3306.1997. J Virol. 1997. PMID: 9060699 Free PMC article.

10

The presence of the Rb c-box peptide in the cytoplasm inhibits p210bcr-abl transforming function.

Guo XY, Balague C, Wang T, Randhawa G, Yuan Z, Bachier C, Greenberger J, Arlinghaus R, Kufe D, Deisseroth AB. Guo XY, et al. Among authors: balague c. Oncogene. 1999 Feb 25;18(8):1589-95. doi: 10.1038/sj.onc.1202479. Oncogene. 1999. PMID: 10102629

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results